+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Novel compound heterozygous laminina2-chain gene (LAMA2) mutations in congenital muscular dystrophy. Mutations in brief no. 159. Online



Novel compound heterozygous laminina2-chain gene (LAMA2) mutations in congenital muscular dystrophy. Mutations in brief no. 159. Online



Human Mutation 12(2): 135



The laminina2-chain gene (LAMA2) encodes a basal lamina protein, laminina2, known to be deficient in one form of congenital muscular dystrophy (CMD). In a laminina2 deficient-CMD patient, we screened the entire LAMA2 cDNA (953bp) by reverse transcriptase polymerase chain reaction combined with single strand conformational polymorphism analysis. Direct sequencing of aberrant conformers in this patient revealed two loss-of-function mutations, consistent with autosomal recessive inheritance. The patient had two novel heterozygous mutations: 1) an exon 4 nonsense mutation caused by a G-->A substitution at cDNA position 547, changing the TGG codon for tryptophan into a TGA stop codon (W166X) in the N-terminus domain VI;ii) an exon 54 frameshift mutation due to a deletion of nucleotide 'C' at cDNA position 7707 (S2553Y), resulting in a premature stop codon (V2587X) in exon 55 in the globular G domain of laminina2 at the C-terminus. These mutations cause a disruption of the open reading frame of LAMA2. The absence of laminina2 observed in the patient's muscle biopsy could result from diminished levels of the LAMA2 transcript. Alternatively, the mutations might lead to translation of a truncated laminina2. By either mechanism the phenotype of congenital muscular dystrophy is believed to be the result of disruption of linkage between the extracellular matrix and the dystrophin glycoprotein complex.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 046825681

Download citation: RISBibTeXText

PMID: 10694916

DOI: 10.1002/(sici)1098-1004(1998)12:2<135::aid-humu10>3.0.co;2-6


Related references

Novel compound heterozygous laminina2-chain gene (LAMA2) mutations in congenital muscular dystrophy. Human Mutation 12(2): 135, 1998

Mutations in the laminin alpha-2-chain gene (LAMA2) cause merosin-deficient congenital muscular dystrophy. Nature Genetics 11(2): 216-218, 1995

Novel LAMA2 Gene Mutations Associated with Merosin-Deficient Congenital Muscular Dystrophy. Iranian Biomedical Journal 22(6): 408-414, 2018

Novel compound heterozygous mutations in the plectin gene in epidermolysis bullosa with muscular dystrophy and the use of protein truncation test for detection of premature termination codon mutations. Laboratory Investigation; a Journal of Technical Methods and Pathology 78(2): 195-204, 1998

LAMA2 gene analysis in congenital muscular dystrophy: new mutations, prenatal diagnosis, and founder effect. Archives of Neurology 62(10): 1582-1586, 2005

Novel mutations in LAMA2 gene responsible for a severe phenotype of congenital muscular dystrophy in two Tunisian families. Archives de l'Institut Pasteur de Tunis 83(1-4): 19-23, 2009

Novel compound heterozygous mutations in the plectin gene in epidermolysis bullosa with muscular dystrophy , and development of protein truncation test for detection of premature termination codon mutations. Journal of Investigative Dermatology 108(4): 562, 1997

Identification of Two Novel LAMA2 Mutations in a Chinese Patient with Congenital Muscular Dystrophy. Frontiers in Genetics 9: 43, 2018

Three novel recessive mutations in LAMA2, SYNE1, and TTN are identified in a single case with congenital muscular dystrophy. Neuromuscular Disorders 27(11): 1018-1022, 2017

Congenital Muscular Dystrophy due to Novel Compound Heterozygote Mutations in POMGNT1 Gene. Journal of Pediatric Neurosciences 13(4): 462-464, 2019

A unique case of limb-girdle muscular dystrophy type 2A carrying novel compound heterozygous mutations in the human CAPN3 gene. European Journal of Neurology 14(7): 819-822, 2007

Novel compound heterozygous mutations in PLEC gene causing epidermolysis bullosa simplex with muscular dystrophy, case series of two affected sisters. Neuromuscular Disorders 27: S112-S113, 2017

Mutations in the laminin a2-chain gene cause merosin-deficient congenital muscular dystrophy. European Journal of Human Genetics 4(SUPPL 1): 94, 1996

Structure of the human laminin alpha2-chain gene (LAMA2), which is affected in congenital muscular dystrophy. Journal of Biological Chemistry 271(44): 27664-9, 1996

Compound heterozygous mutations in the cholesterol side-chain cleavage enzyme gene (CYP11A) cause congenital adrenal insufficiency in humans. Journal of Clinical Endocrinology and Metabolism 87(8): 3808-3813, 2002